ArticleCureus2026
When Gastroenteritis Struck the Brain: Post-infectious Parkinsonism Suggestive of Neuropsychiatric Systemic Lupus Erythematosus in a Patient With Aqueductal Stenosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinsonism is a rare neuropsychiatric manifestation of systemic lupus erythematosus (SLE), the pathogenesis of which has been proposed to involve immune-mediated vasculopathy. Gastrointestinal infections may exacerbate autoimmune responses, triggering disease flares. We present a 26-year-old woman who developed acute parkinsonism with mutism, oromandibular dystonia, and horizontal square wave jerks following a diarrheal illness. Neurological examination revealed cogwheel rigidity and dysphagia. Brain MRI showed periventricular hyperintensities, ventricular dilation, and aqueductal stenosis without basal ganglia infarcts or lesions. Antinuclear antibody was positive (1:100) with anti-SS-A and anti-SS-B antibodies, while complement levels remained within normal limits. Treatment with pulsed methylprednisolone, rituximab, hydroxychloroquine, and levodopa-carbidopa resulted in marked neurological improvement. The patient did not fulfill the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE; however, the clinical features and robust therapeutic response were consistent with a presumptive diagnosis of neuropsychiatric SLE presenting as parkinsonism. This case underscores the importance of considering SLE in young patients with atypical parkinsonism, particularly following a gastrointestinal illness. It highlights that complement levels may not reliably reflect disease activity in all patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.